Selpercatinib in patients with RET fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trial

Detalles Bibliográficos
Autor principal: Stinchcombe, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413039/
https://www.ncbi.nlm.nih.gov/pubmed/37577312
http://dx.doi.org/10.21037/tlcr-23-202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413039/
https://www.ncbi.nlm.nih.gov/pubmed/37577312
http://dx.doi.org/10.21037/tlcr-23-202

Ejemplares similares